Tumor type

Site

Range (%)

Average (%)

Loss of heterozygosity

(LOH)

Glioblastoma

Brain

17 - 70

48 (107/224)

Mostly LOH

Ductal carcinoma

Breast

15 - 48

37 (37/100)

Mostly LOH

Endometrioid

carcinoma

Endometrium

34 - 83

42 (139/334)

LOH and

mutation

Adenocarcinoma

Prostate

17 - 41

33 (49/149)

Mostly LOH

Cystadenocarcinoma

Ovary

6 - 45

33 (65/198)

LOH and

mutation

Melanoma

Skin

32 - 33

33 (18/55)

Mostly LOH

Carcinoma

Thyroid

37

37 (19/51)

Mostly LOH